BRIEF published on 12/02/2025 at 08:35, 2 days 19 hours ago Cie du Bois Sauvage Conducts Share Buy-Back in Late November 2025 Share Buy-back Investor Relations Financial Report NYSE Euronext Brussels Market
REGULATED PRESS RELEASE published on 12/02/2025 at 08:30, 2 days 20 hours ago Cie du Bois Sauvage: Buy back of own shares – week from 24/11/2025 to 28/11/2025 Cie du Bois Sauvage announces buy-back of own shares for the week from 24/11/2025 to 28/11/2025 in compliance with authorization from April 2021 Cie Du Bois Sauvage NYSE Euronext Market Brussels Financial Disclosure Own Shares Buy-back
BRIEF published on 11/25/2025 at 08:35, 9 days 19 hours ago Compagnie du Bois Sauvage's Share Buyback Activity in November Share Buyback Financial Transactions Bois Sauvage NYSE Euronext November 2025
REGULATED PRESS RELEASE published on 11/25/2025 at 08:30, 9 days 20 hours ago Cie du Bois Sauvage: Buy back of own shares – week from 17/11/2025 to 21/11/2025 Cie du Bois Sauvage announces buyback of own shares from 17/11/2025 to 21/11/2025, complying with authorization of 28/04/2021 general meeting. Details of transactions disclosed Cie Du Bois Sauvage NYSE Euronext Market Brussels Trading Own Shares Buyback
BRIEF published on 11/18/2025 at 08:35, 16 days 19 hours ago Cie du Bois Sauvage Announces Share Buyback Transactions Share Buyback Financial Transactions Bois Sauvage Market Activity NYSE Euronext
REGULATED PRESS RELEASE published on 11/18/2025 at 08:30, 16 days 20 hours ago Cie du Bois Sauvage: Buy back of own shares – week from 10/11/2025 to 14/11/2025 Cie du Bois Sauvage disclosed its share buy-back transactions from 10/11/2025 to 14/11/2025, in line with the authorization granted in April 2021. Details available on www.bois-sauvage.be Cie Du Bois Sauvage Share Buy-back Trading Disclosure NYSE Euronext Market Brussels Authorization
BRIEF published on 11/12/2025 at 08:35, 22 days 19 hours ago Compagnie du Bois Sauvage: Share Buyback Activity Share Buyback Financial Disclosure Compagnie Du Bois Sauvage NYSE Euronext Brussels Stock Market Activity
REGULATED PRESS RELEASE published on 11/12/2025 at 08:30, 22 days 20 hours ago Cie du Bois Sauvage: Buy back of own shares – week from 03/11/2025 to 07/11/2025 Cie du Bois Sauvage discloses buy-back of own shares for the week of 03/11/2025 to 07/11/2025, in line with authorization from April 28, 2021 Cie Du Bois Sauvage Trading Disclosure Authorization Own Shares Buy-back
BRIEF published on 09/30/2025 at 08:35, 2 months 4 days ago Cie du Bois Sauvage Reports Share Buyback Activity for Late September 2025 Shares Buyback Financial Market Brussels
REGULATED PRESS RELEASE published on 09/30/2025 at 08:30, 2 months 4 days ago Cie du Bois Sauvage: Buy back of own shares – week from 22/09/2025 to 26/09/2025 Cie du Bois Sauvage discloses share buy-back transactions from 22/09/2025 to 26/09/2025 in compliance with authorization. Details available on www.bois-sauvage.be Cie Du Bois Sauvage Share Buy-back NYSE Euronext Market Brussels Financial Transactions Authorization
Published on 12/05/2025 at 02:35, 1 hour 57 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 32 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 27 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 32 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 2 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 41 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 7 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 17 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 22 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 32 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 47 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 48 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 31 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
